Syros Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hi, everyone. Good afternoon. My name is Adi Jayanthi from the JPMorgan Healthcare Investment Banking team. Thank you all very much for being with us this afternoon. It is my pleasure to introduce Nancy Simonian, CEO of Syros Pharmaceuticals. Without further ado, why don't I pass it right over to Nancy.
Thanks, Adi. And thanks very much for the invitation to speak. I will be making forward-looking statements for a full list of our risk factors, please see our website.
Next slide. Our vision for Syros is to build a great and enduring company that makes a profound difference for patients. I've worked on a number of successful drugs in my career that had made a big difference for patients with cancer, multiple sclerosis and inflammatory bowel disease. And as an industry, we've made significant progress on a lot of diseases, but many more continue to allude effective treatment. And it was clear to me that we needed to be looking for different approaches to drug
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
